New REDUCE-IT data presented at EAS 2026 suggests risk-weighted apoB could better identify residual cardiovascular risk in statin-treated patients with elevated triglycerides. Key Investor ...

Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc analysis of the ...

Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc analysis of the ...

Every day, your liver assembles billions of tiny cholesterol-carrying particles and ships them into your blood. How many it ...

Eligible patients can access Ozempic savings through Felix, alongside continued access to Apo-Semaglutide Felix launches Get Started for Free, waiving the initial $99 clinician visit fee at launch; pa ...

A Canadian generic alternative to the semaglutide drug Ozempic is now available, offering big savings for eligible Ontario ...

When directly comparing the protein content, peanuts have a slight edge over almonds. However, neither peanuts nor almonds ...

LDL cholesterol is an important marker, but others such as ApoB, hs-CRP, and insulin resistance should not be ignored, shares ...

Researchers at UT Southwestern Medical Center have identified a protein that acts as a key regulator of how the liver releases cholesterol carrying ...

Well, I think that -- just taking a step back, I think every investor in credit post-GFC has a greater ear to the ground on the global macro. The interconnectivity of all these markets is critically ...

Findings show lower amyloid PET positivity in Black and Latinx adults with cognitive impairment, highlighting disparities in ...